Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Thoracic Cancer: full-pipeline trial registry
7 of 16 indexed Thoracic Cancer trials are currently recruiting.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 7 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Thoracic Cancer: 16 US clinical trials tracked, 7 recruiting.
Thoracic Cancer is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The New York Proton Center, running 2 of these trials.
Enrollment posture brief
Registry condition thoracic-cancer
OPEN 7 | RECR 44% | LATE 1 | EARLY 1 | RANK #1060 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Distress Syndrome (44% recruiting · 32 trials)
Thoracic Cancer lists 7 open slots (44% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Thoracic Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Thoracic Cancer is recruiting below its size-band peers.
7 of 16 indexed trials (43.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Thoracic Cancer trials is spread across many organizations.
The New York Proton Center accounts for 2 of 16 trials (12.5%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical Thoracic Cancer enrolment sits around 125 participants.
Median target enrolment is 125 among the 16 trials that report a genuine target (sentinel values excluded). 8 of those (50%) plan for fewer than 100 participants.
-
Thoracic Cancer research is mostly interventional.
12 interventional and 4 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
The New York Proton Center
NCT05313191
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Memorial Sloan Kettering Cancer Center
NCT05053230
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Nadine McCleary, MD, MPH
NCT05375643
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Tango Therapeutics
NCT06922591
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
University of California, San Francisco
NCT06633224
Erector Spinae Block for Thoracic Surgery
George Washington University
NCT05521789
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
The New York Proton Center
NCT06342284
Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
Dana-Farber Cancer Institute
NCT05629065
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer
Memorial Sloan Kettering Cancer Center
NCT03794635
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
Varian, a Siemens Healthineers Company
NCT05975619
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
Stanford University
NCT03245788
Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting
Fox Chase Cancer Center
NCT01440855
Early Imaging Biomarkers in NSCLC
University of Michigan Rogel Cancer Center
NCT03121287
Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)
University of Texas Southwestern Medical Center
NCT05459311
VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors
University of Texas Southwestern Medical Center
NCT04686500
Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)
Duke University
NCT04570722
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Thoracic Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Thoracic Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Thoracic Cancer page
16 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Thoracic Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The New York Proton Center sponsors the most Thoracic Cancer trials on record, review their full trial history before evaluating a specific study. See The New York Proton Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thoracic Cancer condition card totals 16 registered trials; most-linked intervention Ipsilateral peripheral IV insertion; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.